JPMORGAN CHASE & CO - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 57 filers reported holding VYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$0171
-5.5%
0.00%
Q3 2022$0181
+5.8%
0.00%
Q2 2022$0
-100.0%
171
-96.8%
0.00%
Q1 2022$3,0005,262
+3013.6%
0.00%
Q4 2021$0
-100.0%
169
-95.5%
0.00%
Q3 2021$5,000
-86.8%
3,784
-65.6%
0.00%
Q2 2021$38,000
-92.9%
11,008
-85.9%
0.00%
Q1 2021$533,00077,8320.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders